VeraLight company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

veralight.com

Founded Year

2004

Stage

Debt | Dead

Total Raised

$50.29M

Last Raised

$200K

About VeraLight

VeraLight, a spinout of InLight Solutions, is a medical device company that is developing Scout, a non-invasive screening device that will detect diabetes and pre-diabetes more accurately and conveniently than current methods. Scout uses fluorescent light to detect changes in a patient's skin indicative of diabetes. Per the company, The Scout test can be performed anywhere, any time, and is simpler than taking blood pressure. VeraLight's non-invasive diabetes screening technology will assist healthcare providers and patients in the global battle against the type 2 diabetes epidemic.

VeraLight Headquarter Location

800 Bradbury SE Suite 217

Albuquerque, New Mexico, 87106,

United States

505-272-7023

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing VeraLight

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

VeraLight is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,750 items

VeraLight Patents

VeraLight has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/26/2007

3/18/2014

Diabetes, Carboxamides, Insulin therapies, Human proteins, Carboxylic acids

Grant

Application Date

12/26/2007

Grant Date

3/18/2014

Title

Related Topics

Diabetes, Carboxamides, Insulin therapies, Human proteins, Carboxylic acids

Status

Grant

Latest VeraLight News

Socrates Health Solutions Developer of Socrates Companion Noninvasive Blood Glucose SelfMonitoring Device Announces Expanded Role of John Maynard

Apr 12, 2018

Maynard was a co-founder and executive vice president of VeraLight which commercialized SCOUT DS, a non-invasive diabetes screening device. Prior to VeraLight, he was a co-founder and vice president of engineering at InLight Solutions, which had a 10-year strategic partnership with the LifeScan division of Johnson & Johnson to develop a noninvasive glucose measurement device. Maynard holds a master’s degree in electrical engineering from Stanford University and has published over 20 peer-reviewed journal articles related to diabetes and its complications. Learn more about John and recent developments at Socrates at: www.socrateshealthsolutions.com . “Socrates has worked closely with John developing our patient testing protocols and broader regulatory planning,” says Scott Smith, CEO, Socrates. “With our recent technology advances, we see John playing a pivotal role in our engineering, quality and manufacturing practices.” Douglas Sutherland, Chairman of the Board of Directors, explains, “With John’s expertise and experience, we have found an individual uniquely qualified to support the conversion of Socrates’ scientific advancements into products ready for broader patient testing, manufacturing and regulatory approval processes.” About Socrates Health Solutions, Inc. Socrates Health Solutions, Inc. is a medical device company focused on the design, development and commercialization of self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM) solutions which are non-invasive and inexpensive. These devices have not yet been cleared by the FDA and are currently not for sale. View source version on businesswire.com: https://www.businesswire.com/news/home/20180412005158/en/ CPR Strategic Marketing Communications

  • When was VeraLight founded?

    VeraLight was founded in 2004.

  • Where is VeraLight's headquarters?

    VeraLight's headquarters is located at 800 Bradbury SE, Albuquerque.

  • What is VeraLight's latest funding round?

    VeraLight's latest funding round is Debt.

  • How much did VeraLight raise?

    VeraLight raised a total of $50.29M.

  • Who are the investors of VeraLight?

    Investors of VeraLight include Psilos Group, Presidio Partners, Signal Peak Ventures, vSpring Capital, Southern Ute and 7 more.

  • Who are VeraLight's competitors?

    Competitors of VeraLight include Viveve Medical, Verax Biomedical, Transcend Medical, Tandem Diabetes Care, InLight Solutions and 12 more.

You May Also Like

M
M2 Group Holdings

M2 Group Holdings is developing a disposable drug delivery system which will initially be used for the treatment of Type I diabetes.

I
Innovia Earcheck Middle Ear Monitor

Innovia EarCheck Middle Ear Monitor is a home-use device that aims to provide a quick and painless way to detect middle ear fluid, a sign of ear infection.

P
Palyon Medical

Palyon Medical is a preclinical-stage medical device company focused on a spin-based drug delivery system.

TheraTogs Logo
TheraTogs

TheraTogs, based in Telluride, Colorado, is a medical device company offering orthotic undergarment and strapping systems that give users with sensorimotor impairment modality for improving postural alignment and stability movement skill and precision and joint stability.

C
CoRepair

CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

Glevel Logo
Glevel

GLevel is a seed stage partnership between Three Arch Partners and Incept which is a syndicate of medical device entrepreneurs and clinicians starting new opportunities in the medical device space.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.